title: Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
authors.affiliation: Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York, USA. dv2117@columbia.edu
authors.forename: Danila
authors.initials: D
authors.lastname: Valmori
authors.forename: Maha
authors.initials: M
authors.lastname: Ayyoub
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology*; D006801:Humans; D008285:Major Histocompatibility Complex / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines